Profusa, Inc. Common Stock (PFSA) Research
Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.
Market snapshot
- Symbol
- PFSA
- Price
- $0.18
- Day change
- -28.84%
- Market cap
- $100.7K
- P/E ratio
- -0.01x
- 52-week range
- 0.1706-412.5
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
Recent news
- What's Going On With Profusa Stock Tuesday?
Profusa ($PFSA) shares down 40% to $1.10. Company signs LOI for $30M acquisition to scale its diagnostics and monitoring business.
- Why Applied Optoelectronics Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Applied Optoelectronics Inc (NASDAQ: AAOI) rose in pre-market trading after securing an 800G transceiver order worth $71 million, bringing total orders from a major customer to $124 million. Other gainers include Xiao-I Corp (NASDAQ: AIXI), Profusa Inc (NASDAQ: PFSA), and Soleno Therapeutics Inc (NASDAQ: SLNO). Losers include Intercont (Cayman) Ltd (NASDAQ: NCT), Visionary Holdings Inc (NASDAQ: GV), and PMGC Holdings Inc (NASDAQ: ELAB).
Peer companies
Recent insider activity
- STOVER JACK E — P-Purchase (0 shares) on 2026-05-04
- Knechtel Fred S. — P-Purchase (0 shares) on 2026-05-04
- Knechtel Fred S. — J-Other (818961 shares) on 2026-01-26
- Knechtel Fred S. — J-Other (516863 shares) on 2026-01-26
- NorthView Sponsor I, LLC — J-Other (5162500 shares) on 2026-01-26
Open Profusa, Inc. Common Stock (PFSA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.